Synthes To Slide ProDisc Into U.S. Artificial Lumbar Disc Market
This article was originally published in The Gray Sheet
Executive Summary
With FDA approval of Synthes' ProDisc artificial disc Aug. 14 for treatment of degenerative disc disease, the firm becomes the second entrant into the U.S. artificial lumbar disc market after J&J/DePuy (Charité)